Optimizing dose-dense regimens for early-stage breast cancer Journal Article

  

Authors:	Morris, P. G.; Hudis, C. A.
Article Title:	Optimizing dose-dense regimens for early-stage breast cancer
Keywords:	cancer chemotherapy; cancer survival; event free survival; overall survival; clinical trial; neutropenia; bevacizumab; doxorubicin; dose response; drug dose comparison; paclitaxel; cancer adjuvant therapy; disease free survival; cancer staging; multiple cycle treatment; breast cancer; blood toxicity; epidermal growth factor receptor 2; cyclophosphamide; high risk patient; febrile neutropenia; early cancer; epirubicin; short survey; trastuzumab; drug dose regimen; recombinant erythropoietin; lapatinib; eribulin
Journal Title:	Nature Reviews Clinical Oncology
Volume:	7
Issue:	12
ISSN:	1759-4774
Publisher:	Nature Publishing Group
Date Published:	2010-12-01
Start Page:	678
End Page:	679
Language:	English
DOI:	10.1038/nrclinonc.2010.188
PROVIDER:	scopus
PUBMED:	21116238
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-78649682851&partnerID=40&md5=1939e87a044c6d0bd867b05075159484
Notes:	--- - "Export Date: 20 April 2011" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/4666